HPV Vaccination Among Females with Mental and Physical Limitation

Rowe, Melissa; Pritt, Audra L.; Stratton, Amanda J.; Yoost, Jennie

doi:10.18590/mjm.2017.vol3.iss2.8

Cited by 9 publications

(11 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Females aged 9–26 years and males aged 9–21 years with special needs had a vaccination rate of 32% (vs 37%) in females and 16% (vs 21%) in males. Previous studies have also indicated the lower vaccination rates; however, these studies were limited to small sample size and geography [[38], [39], [40], [41]].…”

Section: Discussionmentioning

confidence: 99%

Oral HPV prevalence and HPV vaccination among special needs population in the US

Chandrupatla

Khalid

Tavares

2019

Papillomavirus Research

View full text Add to dashboard Cite

IntroductionSpecial needs population have barriers accessing healthcare, higher incidence of sexual assaults and lower sexual education. Due to the above this study was conducted- 1) To assess the current prevalence of oral HPV infection among individuals with SHCN (special health care needs) as compared to the general population and 2) To compare the prevalence of HPV vaccination in SHCN individuals (within the recommended age groups) to general population.MethodsThis data was obtained from NHANES 2013-14 and included 665 individuals with special needs. Weighted prevalence estimates and prevalence ratios (PR) were calculated for oral HPV infection by gender, age (18–59 years), race, smoking history, economic status, and sexual behavior. Prevalence rates were calculated for HPV vaccination.ResultsOral HPV was detected in 9% (7.1–11.5; p = 0.05) of special needs adults. High-risk HPV genotypes prevalence was also higher among adults with special needs [5.56% (3.9–7.9) vs 3.87% (2.7–5.4)]. The HPV vaccination rates among 9–26 years special needs females (33.5% vs 37%) and males aged 9–21 years (16.7% vs 21.2%) with special needs was lower than non-special needs individuals.ConclusionThere is higher burden of oral HPV infection among adults with special needs compared to general population. Contrastingly, lower vaccination rates were observed among them within the recommended age groups. Further studies are required to determine the barriers to HPV vaccination among individuals with special needs.

show abstract

Section: Discussionmentioning

confidence: 99%

Oral HPV prevalence and HPV vaccination among special needs population in the US

Chandrupatla

Khalid

Tavares

2019

Papillomavirus Research

View full text Add to dashboard Cite

show abstract

“…21 Other studies used broad definitions of disability such as: children with special health-care needs (CSHCN), [22][23][24] women with physical disabilities, 25 youth attending specialist schools, 26,27 children with neurological diseases, neurodevelopmental disorders, chronic neurological deficits or developmental disabilities, [28][29][30][31][32] and females with mental and physical limitations. 33 The issue with broad definitions is illustrated by two American studies which found no difference between immunization uptake for people with disabilities as compared to their typically developing peers. The first study measured uptake in a cohort of children with special health-care needs 34 and the second explored whether a medical model of care for children with special health care needs improved immunization rates.…”

Section: Disability Typementioning

confidence: 99%

“…The majority of the studies measured immunization uptake, with 18/28 (64%) calculating the uptake of one or more vaccinations in a population of people with disability. 3,16,[18][19][20][21][22][23][26][27][28][29][30][31][32][33][34]37 The recognition of inequities in immunization services for vulnerable populations relies on the existence of disaggregate data. 38 Aggregate immunization uptake figures do not generally identify small populations at risk for under-immunization 38 and therefore lower immunization coverage in people with disabilities can be missed.…”

Section: Immunization Coveragementioning

confidence: 99%

Vaccination in people with disability: a review

O’Neill

Newall

Antolovich

et al. 2019

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

People with disabilities are vulnerable to complications from vaccine-preventable diseases, and every effort should be made to ensure equitable access to immunization for this population. This paper aims to summarize the research on immunizations in people with disabilities, in order to ensure a comprehensive understanding of knowledge in this area and direct further research. The literature is weighted towards coverage data that is difficult to synthesize because of the different definitions of disability, and the variety of settings, vaccinations and age groups across the studies. In-depth qualitative data and data from a variety of health-care providers and people with disability is notably lacking. This is vital to redress in order to develop effective immunization interventions in this population.

show abstract

“…We would expect findings to be similar for the COVID-19 vaccine since both influenza and COVID-19 can lead to serious health consequences for marginalized groups that may motivate individuals to get vaccinated. In contrast, we would expect different findings for the HPV vaccine since studies show that adolescents with disabilities are less likely to get the HPV vaccine compared to their non-disabled peers ( O’Neill, Elia, et al, 2019 ; Rowe et al, 2017 ). Reasons for these discrepancies are not well understood but may be related in part to poor sexual healthcare and education for those with disabilities ( O’Neill, Elia, et al, 2019 ).…”

Section: Discussionmentioning

confidence: 91%

“…These differences held across a range of participant ages, disabilities, immunization types, and countries of origin ( O’Neill, Elia, & Perrett, 2019 ). For example, researchers found that adolescents with disabilities in both the U.S. and Australia were less likely to initiate or complete Human Papillomavirus (HPV) vaccination schedules compared to their peers ( O’Neill, Elia, & Perrett, 2019 ; Rowe, Pritt, Stratton, & Yoost, 2017 ). Likewise, in a survey study of parental beliefs and practices, researchers found that 50% of participants changed or discontinued their children's vaccination schedules after having a child diagnosed with Autism Spectrum Disorder ( Bazzano, Zeldin, Schuster, Barrett, & Lehrer, 2012 ).…”

Section: Introductionmentioning

confidence: 99%